Is Utibron Neohaler (indacaterol / glycopyrrolate) still available?

No, Utibron Neohaler (indacaterol / glycopyrrolate) has been [discontinued](https://www.epa.gov/sites/default/files/2021-03/documents/epa-hq-oar-2021-0044-0002_attachment_1-mdis.pdf) and is no longer available in the United States. It's not clear why the medication was discontinued.

Utibron Neohaler

Q: What is Utibron Neohaler (indacaterol / glycopyrrolate)?

Utibron Neohaler (indacaterol / glycopyrrolate) is made up of two medications that work to treat COPD. [__Indacaterol__](https://www.goodrx.com/arcapta/what-is) is a long-acting beta agonist (LABA). [__Glycopyrrolate__](https://www.ncbi.nlm.nih.gov/books/NBK526035/) is a long-acting muscarinic antagonist (LAMA), which is also known as an anticholinergic. They both work by relaxing the muscles in your lungs to open up your airways and make it easier for you to breathe.

indacaterol / glycopyrrolate

Used for COPD

Utibron Neohaler (indacaterol / glycopyrrolate) is a combination inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD). It's no longer available in the United States, because it was discontinued.

Reviewed by:

Robert Chad Hakim, PharmD, BCCCP

Cydnee Ng, PharmD

Last reviewed on July 25, 2022

What is Utibron Neohaler (indacaterol / glycopyrrolate)?

What is Utibron Neohaler (indacaterol / glycopyrrolate) used for?

Long-term treatment of COPD

Drug facts

Common Brands	Utibron Neohaler(brand no longer available)
Drug Class	LABA / LAMA
Controlled Substance Classification	Not a controlled medication
Generic Status	No lower-cost generic available
Availability	Discontinued

Common Brands

Utibron Neohaler(brand no longer available)

Drug Class

LABA / LAMA

Controlled Substance Classification

Not a controlled medication

Generic Status

No lower-cost generic available

Availability

Discontinued

Common questions about Utibron

Utibron is made up of two medications that work to treat COPD. Indacaterol is a long-acting beta agonist (LABA). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA), which is also known as an anticholinergic. They both work by relaxing the muscles in your lungs to open up your airways and make it easier for you to breathe.

No, Utibron has been discontinued and is no longer available in the United States. It's not clear why the medication was discontinued.

There are several inhalers on the market that are approved and commonly used for COPD. Examples of available combination inhalers like Utibron include Anoro Ellipta (umeclidinium / vilanterol), Stiolto Respimat (tiotropium / olodaterol), and Duaklir Pressair (aclidinium / formoterol). Review this guide to COPD inhalers and talk to your provider to see which is best for you.

Utibron Neohaler (indacaterol / glycopyrrolate) dosage

Typical dosage for Utibron Neohaler (indacaterol / glycopyrrolate)

What are alternatives to Utibron Neohaler (indacaterol / glycopyrrolate)?

There are a number of medications that your doctor can prescribe in place of Utibron Neohaler (indacaterol / glycopyrrolate). Compare a few possible alternatives below.

Utibron Neohaler (indacaterol / glycopyrrolate)

Used for: